BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
119 hedge funds and large institutions have $1.1B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 36 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
+17
Holders Change %
+16.67%
% of All Funds
2.72%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
25
Increased
45
Reduced
36
Closed
8
Calls
$12.5M
Puts
$2.04M
Net Calls
+$10.4M
Net Calls Change
-$4.81M
Top Buyers
| 1 |
TCIM
TIAA CREF Investment Management
New York
|
+$15.1M |
| 2 |
SC
Samlyn Capital
New York
|
+$11.5M |
| 3 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$7.89M |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$7.51M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$6.57M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$65.8M |
| 2 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$22.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.1M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$8.13M |
| 5 |
State Street
Boston,
Massachusetts
|
-$6.33M |